Average Co-Inventor Count = 4.56
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Intarcia Therapeutics, Inc. (9 from 67 patents)
2. Nektar Therapeutics (3 from 415 patents)
3. Amgen Inc. (2 from 1,975 patents)
4. Scios Inc. (2 from 82 patents)
16 patents:
1. 11246913 - Suspension formulation comprising an insulinotropic peptide
2. 10441528 - Devices, formulations, and methods for delivery of multiple beneficial agents
3. 10363287 - Method of manufacturing an osmotic delivery device
4. 9682127 - Osmotic delivery device comprising an insulinotropic peptide and uses thereof
5. 9572889 - Devices, formulations, and methods for delivery of multiple beneficial agents
6. 8940316 - Osmotic delivery comprising an insulinotropic peptide and uses thereof
7. 8926595 - Devices, formulations, and methods for delivery of multiple beneficial agents
8. 8343140 - Devices, formulations, and methods for delivery of multiple beneficial agents
9. 8299025 - Suspension formulations of insulinotropic peptides and uses thereof
10. 8003665 - Salts and polymorphs of a potent antidiabetic compound
11. 7473433 - Pulmonary delivery of polyene antifungal agents
12. 7223761 - Salts and polymorphs of a potent antidiabetic compound
13. 6838075 - Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
14. 6569406 - Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
15. 6331309 - Hydrogel compositions for the controlled release administration of growth factors